UA Frame EN

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Marialuisa (Anonymous, 37.159.28.) Warszawa 4 months ago

Can Palexia taken with an antidepressant cause interaction or addiction?

Palexia taken with antidepressant
Can it cause interaction or addiction?

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?

Set up a sponsored products campaign yourself:

Check

Katarzyna Kosińska Pharmacist, Editor

4 months ago

Palexia can cause side effects when combined with antidepressants. The most serious interactions are observed in the case of concomitant use of opioid drugs and benzodiazepines (excessive sleepiness, coma, respiratory depression). Concomitant use of Palexia and SSRI antidepressants (e.g. sertraline, citalopram) or SRNI (e.g. venlafaxine) may cause seizures and increase the antidepressant effect of these drugs.

Repeated administration of opioid preparations (e.g. Palexia) can cause tolerance, physical and psychological dependence and opioid use disorder (OUD).

Opioid abuse or deliberate misuse can result in overdose and/or death. The risk of abuse is higher in patients prone to addiction and those burdened with mental illnesses (e.g. severe depressive episodes).

For more information:

https://www.gdziepolek.pl/artykuly/jakie-leki-powoduja-uzaleznienie

https://www.gdziepolek.pl/artykuly/jakie-leki-przeciwbolowe-stosowac

https://www.gdziepolek.pl/kategorie/narkotyczne-leki-przeciwbolowe-opioidy

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists